FDA Inspection
MedX Surgical Partners, Inc.MedX Surgical Partners, Inc. – FDA Inspection, Nov 29, 2010
Record Details
This FDA Inspection record concerns MedX Surgical Partners, Inc., with an inspection on November 29, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- MedX Surgical Partners, Inc.
- Inspection Date
- November 29, 2010
- Product Type
- Biologics
View Company Profile
ID · 4a451e92-31a4-43db-994f-c53e3c1875da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 701437
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
3- 21 CFR 1271.160(a)All core requirements covered in program
- 21 CFR 1271.200(e)Documentation of maintenance and cleaning
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MedX Surgical Partners, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 20, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for MedX Surgical Partners, Inc.
- FDA Inspection 1074160 - 2018-12-06
- FDA Inspection 813840 - 2012-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.